Page last updated: 2024-08-16

propafenone and pf-3450074

propafenone has been researched along with pf-3450074 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Chen, CH; Cocklin, S; Dick, A; Ding, X; Gao, P; Huang, T; Lee, KH; Liu, X; Meuser, ME; Sun, L; Zalloum, WA; Zhan, P1
Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, X; Huang, T; Jiang, X; Kang, D; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Tao, Y; Xu, S; Zalloum, WA; Zhan, P; Zhang, X1
Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, D; Ding, X; Gao, S; Huang, T; Jiang, X; Kang, D; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Tao, Y; Xu, S; Zalloum, WA; Zhan, P; Zhang, X1

Other Studies

3 other study(ies) available for propafenone and pf-3450074

ArticleYear
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    European journal of medicinal chemistry, 2020, Mar-15, Volume: 190

    Topics: Anti-HIV Agents; Capsid Proteins; Cell Line, Tumor; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Dynamics Simulation; Molecular Structure; Phenylalanine; Protein Binding; Structure-Activity Relationship; Triazoles; Virus Replication

2020
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

    Topics: Anti-HIV Agents; Capsid Proteins; Dimerization; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Dynamics Simulation; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Surface Plasmon Resonance

2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Anti-HIV Agents; Benzothiazoles; Capsid Proteins; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Virus Replication

2022